Results 141 to 150 of about 1,800 (153)

Irinotecan

Reactions Weekly, 1999
openaire   +1 more source

Irinotecan

Reactions Weekly, 1993
openaire   +1 more source

Importance of UDP-glucuronosyltransferase 1A1∗6 for irinotecan toxicities in Japanese cancer patients

Cancer Letters, 2008
Kimie Sai, Yoshiro Saito, Nahoko Kaniwa   +2 more
exaly  

Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives

Biomedical Chromatography, 2010
Nuggehally Srinivas
exaly  

Irinotecan

Reactions Weekly, 2013
openaire   +1 more source

ST. JOHN'S WORT INTERFERES WITH IRINOTECAN

Ca-A Cancer Journal for Clinicians, 2002
exaly  

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma

Annals of Oncology, 2003
V Boige, M Fabbro, E Raymond
exaly  

Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation

Annals of Oncology, 2018
Ludovic Barault, Federico Nichetti, Federica Di Nicolantonio   +2 more
exaly  

Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats

European Journal of Pharmaceutical Sciences, 2009
Sushama Talegaonkar, Roop K Khar, Manu Jaggi   +2 more
exaly  

Hexosomes formed from glycerate surfactants—Formulation as a colloidal carrier for irinotecan

International Journal of Pharmaceutics, 2006
Ben Boyd
exaly